Erin Kramp's Legacy

Article

When I heard that Oprah was talking to Peyton Kramp as a part of reliving her favorite shows, it took me back a few years. I remember talking with Erin Kramp, Peyton's mother, a few months before she died of breast cancer in 1998. One of my students at SMU was assisting her with her book and other writing chores at her home not far from the campus and had made an introduction for me. Erin and her husband Doug had already been featured on Oprah where Erin talked about the hours upon hours of video tapes she had made for Peyton. The tapes were filled with the kind of advice only a mother can give, but – more than that – they were filled with Erin and her amazing, light-filled personality. My desire to talk to Erin came from our shared experience of being young mothers with breast cancer, and the fact that she was living out my worst fear -- that I would die and not be here to raise my child. My daughter Kirtley was a year old when I was diagnosed with breast cancer in 1986, and Erin's daughter Peyton was 2 when Erin was diagnosed in 1994. I had spent many sleepless nights wondering how I could leave a legacy for my daughter should my cancer become terminal. Erin was doing just that. But how could she face it emotionally? I wanted to know this woman.Erin and I talked a few times, and I like to think that she thought of me as someone who understood not only her pain but also her determination to leave a legacy for Peyton. She told me that she had already outlived her prognosis by a year and was able to see Peyton reach many of the milestones that occur at 5 and 6. What I remember most is how her faith was evident in everything she did. She firmly believed that if this was to be her path, then she would do it with grace and wisdom. By openly talking about her death, she was living in that place called hopeful reality. She knew she was going to die and she had faced it and accepted it – but at the same time she was living every day to the fullest and working hard to find ways to extend her life as long as possible. It's a difficult place to live, but Erin had embraced it with the same kind of determination she had lived her life. During my time as a breast cancer survivor I have lost many friends to this disease. Each has been a different kind of loss but the most memorable were those who found the same peace Erin did in a resolved death. When you experience such a death it provides a clear picture of how we should all live and die. I liken it to moving into the valley of the shadow of death and getting comfortable, hanging curtains, seeing friends and knowing that the reality is that everyone lives here – they just don't know it. Erin didn't just leave a legacy for Peyton, she left one for all of us.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content